Clinicians working in behavioral health increasingly encounter patients presenting with concerns about their own patterns of behavior — gaming, gambling, pornography use, social media, shopping, and others. What was once a niche area of inquiry has become, gradually and then rapidly, a routine part of clinical practice.
And yet the clinical landscape remains genuinely unsettled.
The formal diagnostic infrastructure is still catching up. The ICD-11 formally recognizes compulsive sexual behavior disorder and gambling disorder as distinct diagnostic entities. Gaming disorder has been added, with acknowledged uncertainty about the evidence base. Other behavioral patterns — compulsive social media use, problematic online shopping, binge eating at the intersection of behavior and biology — occupy varying degrees of diagnostic legitimacy, from emerging consensus to active debate.
This is not a failure of the field. It reflects the inherent difficulty of distinguishing, with precision, between behaviors that are pathological and behaviors that are intense, habitual, or culturally conditioned. The absence of a bright diagnostic line is not an invitation to dismiss patient suffering — it is an invitation to engage with it carefully.
What Assessment Should Actually Do
Rigorous assessment in this area requires more than confirming that a behavior occurs frequently. The core clinical questions are more specific: Is there evidence of loss of control? Has the person made repeated, genuine efforts to reduce or stop? Is there functional impairment — occupational, relational, or otherwise — that is directly attributable to the behavior? And critically: is the distress the patient reports driven by the behavior itself, or by the conflict between the behavior and their values?
This last question carries diagnostic weight. The ICD-11 explicitly excludes from the diagnosis of compulsive sexual behavior disorder cases where distress derives entirely from moral disapproval of one’s own behavior. This is not a technicality. It reflects an important clinical reality: moral incongruence and behavioral dysregulation can produce similar presentations, but they are different problems that respond to different interventions.
Conflating them does not serve patients.
On Treatment
The evidence base for treating behavioral addictions is growing, though unevenly distributed across conditions. Gambling disorder has the most robust literature, with cognitive-behavioral approaches demonstrating consistent efficacy. Motivational interviewing has evidence across multiple behavioral presentations. Pharmacological options exist but remain adjunctive rather than primary, and no medications are approved specifically for most behavioral addictions.
What the evidence consistently supports — across conditions and modalities — is the importance of individualized formulation. Treatment that begins with a precise understanding of the function the behavior serves, the factors maintaining it, and the patient’s own goals is more likely to be effective than treatment that begins with a protocol.
This is not a criticism of structured approaches. It is a reminder that structure serves the patient, not the other way around.
What Remains Uncertain
Intellectual honesty requires naming what we do not yet know. The neurobiological parallels between substance use disorders and behavioral addictions are suggestive but not settled. Prevalence estimates vary widely depending on the assessment tool used, the population studied, and the diagnostic threshold applied. Long-term outcome data for most behavioral addiction treatments is limited.
The clinical implication is not paralysis. It is appropriate epistemic humility — treating the patient in front of you with the best available evidence while remaining open to revision as the science develops.
That is, in the end, what good clinical practice looks like in any domain.
